[ RadSafe ] [Nuclear News] Nuclear power enters global warming debate
Sandy Perle
sandyfl at cox.net
Mon Apr 9 10:51:47 CDT 2007
Index:
Nuclear power enters global warming debate
OSHA Seeks Input From Stakeholders On Ionizing Radiation
Nuclear energy and metal processing plant in far-eastern Russia
On the hunt for radiation around Vermont Yankee
NNSA sets up new radiation exposure lab
Duke Researchers Quick Test That Could Detect Exposure to Radiation
Ahmadinejad arrived at Natanz to inspect its nuclear facilities
Nuclear reactor may restart at half-power after fire
IMV Reports Increased Use of Image-Guided Radiotherapy
--------------------------------------------------------------
Nuclear power enters global warming debate
Legislation to cut greenhouse gas emissions creates new alliances and
opens old wounds on Capitol Hill.
WASHINGTON (LA Times) Apr 9 - The renewed push for legislation to cut
greenhouse gas emissions could falter over an old debate: whether
nuclear power should play a role in any federal attack on climate
change.
Congress, with added impetus from a Supreme Court ruling last week,
appears more likely to pass comprehensive energy legislation. But
nuclear power sharply divides lawmakers who agree on mandatory caps
on carbon dioxide emissions. And it has pitted some on Capitol Hill
against their usual allies, environmentalists, who largely oppose any
expansion of nuclear power.
House Speaker Nancy Pelosi and Sen. Barbara Boxer - Bay Area
Democrats with similar political views - are on opposite sides.
Pelosi used to be an ardent foe of nuclear power but now holds a
different view. "I think it has to be on the table," she said.
Boxer, head of the Senate committee that will take the lead in
writing global warming legislation, said that turning from fossil
fuels to nuclear power was "trading one problem for another."
Sens. John McCain (R-Ariz.), Barack Obama (D-Ill.) and Hillary Rodham
Clinton (D-N.Y.) - all presidential candidates - support legislation
that would cap greenhouse gas emissions and provide incentives to
power companies to build more nuclear plants.
Opponents of nuclear power say that because a terrorist attack on a
plant could be catastrophic, it makes no sense to build more
potential targets. And radioactive waste still has no permanent
burial site, they say, despite officials' three decades of trying to
find one.
But attitudes toward nuclear power may be shifting as a consensus
emerges that greenhouse gases are causing the world to heat up.
The Supreme Court added its voice, criticizing the Bush
administration for not acting to control greenhouse gases.
Max Schulz, a former Energy Department staff member who is a senior
fellow at the Manhattan Institute, a conservative think tank, said
the ruling could help "spur the revival of nuclear power."
And congressional Democratic leaders have made passage of global
warming legislation a priority.
"I've never been a fan of nuclear energy," said Sen. Dianne Feinstein
(D-Calif.), who has called it expensive and risky. "But reducing
emissions from the electricity sector presents a major challenge. And
if we can be assured that new technologies help to produce nuclear
energy safely and cleanly, then I think we have to take a look at
it."
The public's attitude toward nuclear power is more favorable when
such energy is seen as part of an effort to fight climate change.
Polls over the years have shown that a slim majority backs nuclear
power, but a Los Angeles Times/Bloomberg survey last summer found
that a larger majority, 61%, supported the increased use of nuclear
energy "to prevent global warming."
Legislation introduced recently in California seeks to repeal a 1976
ban on new nuclear plants in the state.
"There's no question that the attention to climate change over the
last several years has materially changed the public discussion of
nuclear power," said Jason Grumet, executive director of the National
Commission on Energy Policy, a bipartisan group of energy experts.
Given the threat of global warming, he said, "it's hard to ignore the
principal source of noncarbon power generation in the country today."
One environmental group has tried to keep an open mind. "We don't
think any options should be taken off the table when dealing with
global warming," said Environmental Defense spokesman Charlie Miller.
The nuclear power industry in the U.S. has been at a virtual
standstill because of high construction costs, regulatory
uncertainties and public apprehension after a 1979 accident at
Pennsylvania's Three Mile Island.
A number of plants ordered before the accident went into operation.
But many more were canceled after one of the Three Mile Island
reactors suffered a partial meltdown and small amounts of radiation
were released into the atmosphere.
Reviving the industry has been a priority for President Bush, who
sees nuclear power as crucial to meeting a growing demand for
electricity.
The Nuclear Regulatory Commission expects to receive applications for
about two dozen new plants in the next few years - in part because of
provisions in a 2005 energy bill designed to promote nuclear power.
Currently, 103 nuclear plants - including Diablo Canyon near San Luis
Obispo and San Onofre in northern San Diego County - generate about
20% of the nation's electricity.
The amount of congressional support for nuclear power is unclear.
When McCain and Sen. Joe Lieberman (I-Conn.) added subsidies for
nuclear power to their 2005 bill to cut greenhouse gas emissions,
they lost support from environmentalists and votes in Congress,
including Boxer's.
McCain said he had no idea whether he would be more successful this
time. But he said there was "no way that you could ever seriously
attack the issue of greenhouse gas emissions without nuclear power,
and anybody who tells you differently is not telling the truth."
On Capitol Hill last month, former Vice President Al Gore, who has
become a leading advocate for swift action on climate change, said he
saw nuclear plants as a "small part" of the strategy.
"They're so expensive, and they take so long to build, and at present
they only come in one size: extra large," he said.
"And people don't want to make that kind of investment in an
uncertain market for energy demand."
The McCain-Lieberman bill, which seeks to reduce greenhouse gas
emissions by 2050 to a third of 2000 levels, would provide federal
loans or guarantees to subsidize as many as three advanced reactor
projects.
The U.S. Public Interest Research Group and Public Citizen said the
bill would authorize more than $3.7 billion in subsidies for new
nuclear plants.
Sen. Thomas R. Carper (D-Del.), a cosponsor of the McCain-Lieberman
legislation, thinks support for nuclear power could bring more votes.
"Three or four years ago, if you included nuclear, you lost more than
you gained," he said. "Today ... you pick up more than you lose."
But nuclear power faces huge political and economic obstacles.
Senate Majority Leader Harry Reid (D-Nev.) remains opposed to the
planned Yucca Mountain nuclear waste disposal site in his state.
And Philip E. Clapp, president of the National Environmental Trust,
said he did not think subsidies could overcome the concerns of
potential investors. "There isn't enough money in the federal till to
change Wall Street's calculation of the financial risks," he said.
Even some lawmakers who support nuclear power question whether the
industry needs more federal money.
Sen. Jeff Bingaman (D-N.M.), chairman of the Senate Energy and
Natural Resources Committee, sees nuclear power as a "mature
industry," said Bill Wicker, his spokesman. "Emerging climate-
friendly and genuinely renewable technologies like wind and solar and
geothermal and biomass could use that [funding] boost," Wicker said.
Some environmentalists remain steadfastly opposed to nuclear power.
"Investments in energy conservation and renewable energy are quicker,
more cost-effective and sustainable ways to reduce global warming
emissions," said Erich Pica of Friends of the Earth, which will
oppose McCain's bill as long as it contains subsidies for nuclear
power.
Such environmentalists also note that carbon emissions from nuclear
fuel processing are significant. They say the costs and risks of
nuclear power are too high and far greater than alternatives, such as
solar and wind power.
"Switching from coal to nukes," said Dan Becker, director of the
Sierra Club's global warming program, "is like giving up smoking and
taking up crack."
-------------------
OSHA Seeks Input From Stakeholders On Ionizing Radiation
Agency announces dates of final two meetings
Washington, DC Apr 9 - The Occupational Safety and Health
Administration (OSHA) invites the public to participate in its final
two informal stakeholder meetings on Occupational Exposure to
Ionizing Radiation in a Federal Register Notice published March 30,
2007. These planned meetings continue OSHA's information collection
efforts and will add to the information obtained under the Request
for Information published on May 5, 2005.
"These meetings are an exceptional opportunity for us to hear from
stakeholders and exchange data, share ideas and varying points of
view on how to work safely with sources of ionizing radiation," said
Assistant Secretary of Labor for OSHA, Edwin G. Foulke, Jr.
The next stakeholder meeting will be held from 8:30 a.m. to 1:00 p.m.
on April 19, 2007, at the Crowne Plaza Chicago O'Hare Hotel, 5440
North River Road, Rosemont, Ill., 60018. This meeting will cover
accelerator operations.
The final meeting will be held from 8:30 a.m. to 4:30 p.m. on April
26, 2007, at the Department of Labor, Frances Perkins Building, 200
Constitution Ave., N.W., Washington, D.C. 20210. The meeting will
cover the uses of ionizing radiation for security activities.
OSHA requests the public be prepared to discuss the following issues
regarding occupational exposure to ionizing radiation in their
industry/occupation: uses of ionizing radiation, controls utilized to
minimize exposure and available exposure data and training.
Those who wish to participate in a stakeholder meeting must notify
OSHA by e-mail at navas.liset at dol.gov, FAX at (202) 693-1678, or by
mail to Liset Navas, Directorate of Standards and Guidance,
Occupational Safety and Health Administration, U.S. Department of
Labor, Room N3718, 200 Constitution Ave., N.W., Washington, D.C.
20210 no later than April 11, 2007.
---------------
Nuclear energy and metal processing plant in far-eastern Russia
MOSCOW (Thomson Financial) Apr 9 - Russian aluminium producer Rusal
and Russian nuclear energy agency Rosatom said they are to begin to
work on plans to build a vast nuclear energy and metal processing
plant in far-eastern Russia.
An agreement signed by both parties stated they had agreed to carry
out "a detailed exploration of the opportunities to create an energy
and metals complex in the Far East, notably a nuclear power station
and an aluminium blast furnace."
A feasability study for the project is to be carried out before the
end of the year, with a construction calendar to be defined
thereafter.
The statement did not give details of where the complex might be
located.
----------------------
On the hunt for radiation around Vermont Yankee
VERNON, Vt. Bill Irwin of Burlington is the state of Vermont's
radiation checker.
Four times a year he takes a two-day tour of Windham County with a
representative of the Vermont Yankee nuclear power plant to check
radiation monitors installed near the plant.
Irwin is radiological health chief for the Vermont Department of
Health. He joined the department in 2005, after stints working in
radiation safety at the Seabrook nuclear plant in New Hampshire and
in Massachusetts.
Just how much radiation is being emitted by Vermont Yankee has been a
bone of contention recently.
The Health Department reported that the plant had exceeded the state
limit of 20 milirems per year in 2004.
Vermont Yankee disagreed, and the two agreed to bring in a consultant
to study the issue.
Last month, Oak Ridge Associated Universities reported that the state
limit most likely had not been exceeded.
-------------------
NNSA sets up new radiation exposure lab
WASHINGTON, April 9 (UPI) -- The U.S. National Nuclear Security
Administration has set up a new facility to help identify radiation
exposure levels.
"In the event of a nuclear or radiological accident or terrorist
attack, NNSA's new Cytogenetics Biodosimetry Laboratory in Oak Ridge,
Tenn., will be able to help determine the amount of radiation that a
potential victim has been exposed to so that physicians can better
formulate treatment plans," the NNSA, an agency of the U.S.
Department of Energy, said in a statement.
"Determining the amount of radiation exposure can ultimately mean the
difference between life and death for the victims," said Joseph Krol,
the head of NNSA's emergency operations. "This facility is absolutely
unique within the civilian community and it will help to ensure that
our nation is ready and able to respond to a nuclear emergency. We
are very pleased that NNSA was able to provide the federal leadership
necessary to re-establish this important national security
capability."
"Cytogenetic biodosimetry is a proven method for accurately
estimating how much exposure a person has had to radiation," the NNSA
statement said. "A cytogenetics laboratory operated at Oak Ridge
until 1998, and after that the military had the nation's only
cytogenetic capability.
"With the increased focus on nuclear terrorism since the 9/11
terrorist attacks, NNSA decided to re-establish civilian cytogenetic
capabilities by constructing an improved laboratory," the statement
said. "The new CBL was jointly funded by NNSA, the Department of
Energy's Office of Worker Safety and Health, and the Nuclear
Regulatory Commission," it said.
The NNSA said the new lab would be run as part of its Radiation
Emergency Assistance Center/Training Site, or REAC/TS, in the Oak
Ridge Institute for Science and Education.
--------------------
Duke Researchers Develop Quick Test That Could Detect Exposure to
Radiation
DURHAM, N.C. -- In the event of a nuclear or radiological
catastrophe, such as a nuclear accident or a "dirty bomb,"- thousands
of people would be exposed to radiation, with no way of quickly
determining how much of the deadly substance has seeped inside their
bodies.
Scientists at Duke University Medical Center have developed a new
blood test to rapidly detect levels of radiation exposure so that
potentially life-saving treatments could be administered to the
people who need them most.
There appears to be a critical window of 48 to 72 hours for
administering treatments aimed at halting the devastating effects of
radiation, said senior study investigator John Chute, M.D., an
associate professor of medicine in the Duke Adult Bone Marrow and
Stem Cell Transplant Program. But existing tests for measuring
radiation exposure take several days and are not practical for
testing large numbers of patients at once.
"If a terrorist attack involving radioactive material were to occur,
hospitals might be overrun with people seeking treatment, many of
whom have actually been exposed and many of whom are simply
panicked," Chute said. "We have to be able to efficiently screen a
large number of people for radiation exposure in order to respond
effectively to a mass casualty event."
The new test scans thousands of genes from a blood sample to identify
distinct genomic "signatures" reflecting varying radiation doses.
Patients can then be handled according to whether they received no
exposure to radiation, an intermediate level of exposure that may
respond to medical therapies or an inevitably lethal dose.
The researchers published their findings April 3, 2007, in the
journal Public Library of Science (PLoS) Medicine. The research was
funded by the National Institute of Allergy and Infectious Diseases.
High doses of radiation can damage or wipe out a person's blood and
immune systems, leading in some cases to bone marrow failure
accompanied by infections, bleeding and a potentially heightened
lifetime risk of cancer. Since the symptoms of radiation exposure can
take days or weeks to develop, it could be difficult to identify
individuals truly exposed without a practical test to make this
distinction, the researchers said. Current treatments for radiation
exposure aim to bolster the blood and immune systems before the
damage becomes too severe.
Previous studies by researchers at the Duke Institute for Genome
Sciences & Policy have used genomic technology to identify genes that
can predict prognosis and response to chemotherapy within several
types of cancers. In the current study, the Duke team used a similar
strategy to determine which genes change in response to different
levels of radiation exposure.
The researchers subjected mice to low, intermediate and high doses of
radiation and looked for the impact of each dose on specific genes in
the blood. They found that each dose resulted in distinct profiles,
or signatures, representing 75 to 100 genes that could be used to
predict the degree of exposure.
They also analyzed blood from human patients receiving bone marrow
transplants who were treated with high doses of radiation prior to
transplant and found specific gene profiles that distinguished the
individuals that were exposed to radiation from those that were not
with an accuracy of 90 percent.
"The goal now is to refine this test to the point that if a disaster
were to occur, we could draw blood from thousands of people and have
results back in time for treatment to have effect," said Joseph
Nevins, Ph.D., a professor of molecular genetics and a researcher at
the Duke Institute for Genome Sciences & Policy and co-investigator
on the study.
These findings also could point to new treatments for victims of a
radiological catastrophe, said lead study investigator Holly K.
Dressman, Ph.D., an associate professor of molecular genetics and a
researcher at the Duke Institute for Genome Sciences & Policy. "By
identifying genes that are major players in the response to
radiation, we hope to compile a list of future targets for protection
against its harmful effects."
The researchers are currently refining the test by looking at the
effects of time from exposure, gender, age and additional genetic
factors on the ability of the test to predict radiation dose,
Dressman said.
Other researchers participating in the study were Geoff S. Ginsburg
of the Duke Institute for Genome Sciences & Policy and Garrett G.
Muramoto, Nelson J. Chao, Sarah Meadows and Dawn Marshall of the Duke
Department of Medicine, Division of Cellular Therapy.
-------------------
Iran-Nuclear-Ahmadinejad - President Mahmoud Ahmadinejad arrived at
Natanz on Monday to inspect its nuclear facilities.
Upon arrival at Natanz, which is situated 100 kms to the north of the
capital city of Isfahan province in central Iran, the chief executive
started inspecting various sections of this nuclear site.
The National Day of Nuclear Technology is scheduled to be celebrated
this afternoon in an official ceremony in the presence of
Ahmadinejad, a number of his cabinet members and MPs as well as
ambassadors of foreign countries to Tehran.
The president is expected to declare a good news about another
achievement made by Iran in peaceful nuclear field.
--------------------
Nuclear reactor may restart at half-power after fire
BUCHANAN, N.Y. A nuclear power reactor north of New York City might
restart at low power after a fire in a transformer forced a shut-
down.
That's according to a spokesman for the operators of the Indian Point
3 reactor along the Hudson River. The plant has two transformers, and
he says it could run at half-capacity with just one.
The reactor is facing tighter inspections after Friday's fire, though
the Nuclear Regulatory Commission says there was no release of
radiation, and no harm to public health and safety. The fire was
outside the nuclear area.
It was Indian Point 3's fourth unplanned shut-down since July, and
the second in a week. A water pump malfunction closed the plant down
from 4 a-m Tuesday to 1 a-m Wednesday.
-----------------
IMV Reports Increased Use of Image-Guided Radiotherapy in Radiation
Oncology
According to a recent study published by IMV Medical Information
Division, patients made an estimated 23.2 million radiation therapy
or related visits in the US, including 19.0 million treatment visits
and 4.2 million allied visits in 2006. The top three cancer site
types include breast, prostate and lung cancer, which account for
21%, 20% and 12%, respectively, of all cancer site types treated
using radiation therapy.
"While the number of patients treated with radiation therapy every
year is relatively stable, the technological sophistication of
radiation oncology departments is continuing to advance. Digital
imaging has become integrated into treatment planning and to guide
tumor treatment real-time," observed Lorna Young, Senior Director,
Market Research. "While in 2004, 15% of the radiation oncology sites
provided Image Guided Radiotherapy (IGRT) in their department, over
one-third of the sites do so now, using either a dedicated IGRT
imaging device or electronic portal imaging. Ultrasound, x-ray and CT
are the primary imaging modalities used in IGRT."
IMV's 2006 Radiation Oncology Market Summary Report describes trends
in the adoption of therapeutic techniques, equipment and radioactive
agents. Equipment types covered include linear accelerators, CT and
PET/CT simulators, treatment planning systems, IGRT, record and
verify / information management systems, remote afterloader
brachytherapy and dedicated radiosurgery. Other technologies covered
include IMRT, inverse planning, conformal radiotherapy,
intraoperative radiation therapy (IORT), stereotactic radiosurgery
and prostate seed therapy. Highlights include:
90% of the radiation therapy sites use networks for sharing images
used in treatment planning.
CT simulators comprised over 80% of the simulators installed in 2006.
Sites having budgets of $1.5+ million have increased from 15% of 2003
capital budgets to 33% of 2007 budgets.
85% of the sites indicated that they have "record and verify /
information management" systems installed.
The data source for this report is IMV's 2006/07 Radiation Oncology
Census Database, which provides comprehensive profiles of radiation
oncology sites in the United States. The database can be licensed by
qualified subscribers and includes contact and site-specific
information. Applications of the database include market analysis,
market development, target marketing, lead generation, installed base
marketing programs, sales territory deployment and competitive
analysis.
For more information about IMV's Radiation Oncology Census Database
and Market Summary Report, visit the corporate website at
www.imvinfo.com or call 847-297-1404 to speak with a representative.
IMV Medical Information Division is a marketing research and
consulting firm founded in 1977, specializing in medical imaging and
other advanced healthcare technology markets. IMV's marketing
consulting services, in combination with our census databases of U.S.
imaging sites with selected modalities, provide clients valuable
assistance in strategic planning, customer satisfaction, product
development and sales initiatives. Current census databases include
interventional angiography, radiographic fluoroscopy, cardiac
catheterization, CT, MRI, nuclear medicine, echocardiography, PET,
radiation oncology, X-ray/DR/CR and RIS/PACS.
Sandy Perle
Senior Vice President, Technical Operations
Global Dosimetry Solutions, Inc.
2652 McGaw Avenue
Irvine, CA 92614
Tel: (949) 296-2306 / (888) 437-1714 Extension 2306
Fax:(949) 296-1144
E-Mail: sperle at dosimetry.com
E-Mail: sandyfl at cox.net
Global Dosimetry Website: http://www.dosimetry.com/
Personal Website: http://sandy-travels.com/
More information about the RadSafe
mailing list